...RET) encodes a receptor tyrosine kinase that is essential for neural, renal, and thyroid development. Pathogenic RET alt...
...RET inhibitors are approved for treatment of RET-mutant lung and thyroid cancers. RET mutation is a druggable molecular ...
...RET, and ATM genes, with RET-NCOA4 fusions observed in the LM subgroup. CONCLUSION: LM is common in pPTC, and NMLNs > 14...
...RET. As cellular events following RET cannot be fully controlled clinically, the risk of unfavourable outcomes should be...
...RET mutation, establishing hereditary MTC. CEA elevation is commonly evaluated for GI malignancies. This case report hig...
...RET, ROS1, and NTRK fusions, along with BRAF V600E, KRAS G12C, and HER2 mutations. While these alterations collectively ...
...RET% by week 2. TEAEs incidences were comparable (enarodustat: 90.0%, rHuEPO: 90.0%), with no additional safety concerns...
...RET fusion gene, demonstrating intratumoral genetic heterogeneity. The patient was successively treated with an EGFR-TKI...
...RET Lys666Asn variant. METHODS: Index patients carrying the RET Lys666Asn variant were identified through clinical genet...
...retinal (RET), global head (GLO), and occipital (OCC). Perception probability was modeled using mixed-effects logistic r...
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话: 0531-88819269